BIEL
BIOELECTRONICS CORP
Latest price
As of Oct 30, 2026, 3:48 PM EDT · Market data by Massive
Market cap
—
Volume
4M
Previous close
$0.0003
Day range
$0.0002 – $0.0003
Listed
—
Coverage
6 articles
Price performance
Recent trading
Newsroom
Latest BIEL coverage
BioElectronics Corporation Announces the Publication of Pilot Study Results
[ad_1] Beneficial Treatment Effect for Phantom and Residual Limb Pain Identified FREDERICK, MD – (NewMediaWire) – February 23, 2024 – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the publication of a study investigating the treatment of phantom and residual limb
NewMediaWire | BioElectronics Chairman Updates Investors
[ad_1] Discusses Clinical Trial Progress and Potential Legal Action Against MundiPharma FREDERICK, MD – (NewMediaWire) – February 15, 2024 – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today releases an update from its Chairman, Richard Staelin, PhD. The intent of this short up
End of Year Message From the Chairman of the Board of BioElectronics
[ad_1] FREDERICK, MD – (NewMediaWire) – December 22, 2023 – BioElectronics Corp. (OTC: BIEL) is pleased to provide this end of year message to investors, customers, suppliers and other partners. As described below, the last six months have produced mixed results. Research Update We have seen good progress on the research side. An investig
BioElectronics' Chairman Discusses Recent Clinical Research Findings
[ad_1] Company Receives Initial Purchase Order From Stada MENA FREDERICK, MD – (NewMediaWire) – July 22, 2022 – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced via a Shareholder’s update that the Company has completed and undertaken additional clinical research and
BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements
[ad_1] FREDERICK, MD – (NewMediaWire) – February 28, 2022 – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) is pleased to update, in a letter from its Chairman, Richard Staelin, Ph.D., new distribution partners, personnel changes, and new clinical research studies. SALES UPDATE: BioElectronics Corporation is pleased to ann
BioElectronics Corporation Reports Q3 Earnings
[ad_1] Year over Year Revenue Growth Exceeds 463% FREDERICK, MARYLAND – (NewMediaWire) – November 16, 2021 – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) announces a 463% increase in sales revenue resulting in a profitable 3rd quarter. Keeping in line with BIEL’s impressive year-over-year growth, the nine months ended